暗記メーカー
ログイン
DDS
  • Hannah Angelique Losaria

  • 問題数 33 • 3/25/2024

    記憶度

    完璧

    4

    覚えた

    14

    うろ覚え

    0

    苦手

    0

    未解答

    0

    アカウント登録して、解答結果を保存しよう

    問題一覧

  • 1

    an agent intended for use in the diagnosis, treatment, mitigation, cure, and prevention of disease in man or animals the component which produces the pharmacological activity

    drug

  • 2

    INACTIVE ingredient present in a dosage form vehicle, suspending agents, lubricants, binders

    excipient

  • 3

    FINISHED DOSAGE FORM that conatins the active ingredient, but NIT necessarilly, in association with one or more other ingredients

    drug product

  • 4

    formulation containing a specific quantity of active inredient/s in combination with one or more excipients. •provides mechanism for the safe and convenient delivery of drugs •concealment of offensive taste. •protection from destructive influence of the environment

    dosage form

  • 5

    means of administering drugs as formulated preparation •formulation which provide a therapeutic amount of drug to the proper site in the body promptly and maintain the desired drug concentration products that allow for the uniform release or targeting of the drugs into the body

    DDS

  • 6

    defined by the FDA as an active ingredient that has never before been marketed in the US

    new molecular entity NME

  • 7

    a prototype medical compound that has a fundamental desired biologic or pharmacologic activity

    lead component

  • 8

    produces specifically the desired effect •administered by the most desired route (orally) •minimal dosage and dosage frequency •has optimal onset and duration of activity •easily produced at low cost

    goal drug

  • 9

    a compound that requires metabolic biotransformation after administration to produce the desired pharmacologically active compound.

    prodrug

  • 10

    The FDA provides support grants to conduct clinical trials on safety and effectiveness

    orphan drug

  • 11

    is defined as a rare disease or condition that affects fewer than 200,000 people in the US

    orphan disease

  • 12

    permits the use of an investigational drug in the tx of px not enrolled in the clinical study but who have a serious or IMMEDIATELY LIFE THREATENING disease for which there is no satisfactory alternative therapy

    treatment IND

  • 13

    dosage form without containing any medication

    placebo

  • 14

    cause serious adverse effect or death

    class 1

  • 15

    cause temporary or medically reversible adverse health consequences

    class 2

  • 16

    not likely to cause adverse health consequences

    class 3

  • 17

    initial bioassay that takes place OUTSIDE the organism, in an artificial environment such as laboratory

    in vitro

  • 18

    sunsequent bioassay by biological experiment or technique carried out within a living organism

    in vivo

  • 19

    most famous surviving memorials of early drugs with more than 800 formulas or prescriptions

    papyrus ebers

  • 20

    is the process in which the solid ingredients are placed in a stoppered container with the whole of the solvent and allowed to stand for a period of at least three days. with frequent agitation.

    maceration

  • 21

    is where the active ingredients are extracted from a macerated drug mass in a narrow shaped vessel open at both ends through the passage of an extracting liquid called menstrum

    percolation

  • 22

    this is a form of maceration in which gentle heat is used during the process of extraction

    digestion

  • 23

    is a dilute solution of a readily soluble constituents of crude drugs for a short period of time which either cold or boiling water is added

    infusion

  • 24

    extracts water soluble and heat stable constituents from crude drugs by boiling in water for 15 minutes, cooling, straining and passing sufficient cold water through the drug to produce required volume

    decoction

  • 25

    are plastic masses containing 15% gelatin, 40% glycerin, 35% water, and 10% added medicinal substance

    glycerogelatins

  • 26

    are semi solid preparations intended for application to the skin, and generally contain a larger proportion of solid material than ointments and therefore are stiffer

    paste

  • 27

    are generally suspensions of solid materials in an aqueous vehicle

    lotion

  • 28

    often used to describe suspensions of inorganic acids such as clay in water

    magma

  • 29

    is sometimes used in suspensions in aqueous vehicles intended for oral

    milk

  • 30

    are semi solid systems consisting of dispersions of small or large molecules in an aqueous liquid vehicle rendered as jelly like by the addition of gelling agent

    gels

  • 31

    semisolid preparations containing one or more medicinal agents dissolved or disoersed in either ow emulsion or wo emulsion or in another type of water washable base

    cream

  • 32

    do not contain oleaginous components completely water washable greaseless

    water soluble bases

  • 33

    ow emulsions resembling creams easily washed from the skin water washable

    water removable bases